CopyFind
DIENOGESTE

DIENOGESTE

20,99 R$

Макс. цена для потребителя (CMED)

Аналоги DIENOGESTE

Найдите более доступные аналоги и дженерики для DIENOGESTE.

Ингредиенты

Активный ингредиент: dienogeste


Описание товара

About DIENOGESTE

DIENOGESTE is a prescription medicine containing the active hormone dienogeste. It is used primarily for the management of endometriosis and for the treatment of moderate to severe dysmenorrhea. The medication is administered orally once daily, typically at the same time each day. DIENOGESTE is formulated to provide a steady release of the active ingredient, helping to reduce pain and inflammation associated with endometriosis and to regulate menstrual cycles. Patients may experience a reduction in pelvic pain, fewer menstrual cramps, and a decrease in the need for additional pain medication. The product is supplied in blister packs containing 28 tablets, and a new pack is usually prescribed each month. The medication is intended for use under the supervision of a qualified healthcare professional, who will determine the appropriate duration of therapy based on the patient’s condition and response to treatment.

Key Benefits & Uses

  • Effective relief of endometriosis-associated pain
  • Reduction of dysmenorrhea severity and frequency
  • Regulation of menstrual cycle and reduction of heavy bleeding

Active Ingredient & Action

The active ingredient, dienogeste, is a synthetic progestogen that selectively binds to progesterone receptors. By modulating hormone levels, it suppresses the growth of endometrial tissue, decreases estrogen-driven proliferation, and reduces inflammatory mediators. This mechanism results in a decrease in pain and a reduction in the size of endometrial implants. The drug’s pharmacokinetic profile allows for once-daily dosing with a relatively low risk of breakthrough bleeding.

Important Notes

DIENOGESTE should be taken exactly as prescribed by a healthcare professional. Patients should inform their provider of any history of blood clots, liver disease, or hormone-sensitive cancers. The medication is not recommended for use during pregnancy or breastfeeding unless specifically advised by a clinician. Regular follow-up appointments are advised to monitor efficacy and any potential side effects. If any unusual symptoms occur, patients should seek medical attention promptly.

Оценки посетителей

Помогите другим — оцените полезность этой страницы.

Оценок пока нет — будьте первым.